La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
(—)‐methamphetamine < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine < 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (administration & dosage)  Facettes :

List of bibliographic references indexed by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Number of relevant bibliographic references: 41.
[0-20] [0 - 20][0 - 41][20-40]
Ident.Authors (with country if any)Title
000273 (2016) Mohammed Filali [Canada] ; Robert Lalonde [France]Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP.
000801 (2015) Vincent A. Jourdain ; Nicolas Morin ; Laurent Grégoire ; Marc Morissette ; Thérèse Di PaoloChanges in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
000995 (2014) Marianna Sikorska [Canada] ; Patricia Lanthier [Canada] ; Harvey Miller [Canada] ; Melissa Beyers [Canada] ; Caroline Sodja [Canada] ; Bogdan Zurakowski [Canada] ; Sandhya Gangaraju [Canada] ; Siyaram Pandey [Canada] ; Jagdeep K. Sandhu [Canada]Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson’s disease
000B04 (2014) Jean-Francois Poulin ; Jian Zou ; Janelle Drouin-Ouellet [Royaume-Uni] ; Kwang-Youn A. Kim ; Francesca Cicchetti ; Rajeshwar B. AwatramaniDefining midbrain dopaminergic neuron diversity by single-cell gene profiling
001130 (2012) Mélanie Bourque [Canada] ; Dean E. Dluzen ; Thérèse Di PaoloSignaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease.
001D17 (2010) QINGJIA MENG [Canada] ; Dirk W. Luchtman [Canada] ; BOUCHAIB EL BAHH [Canada] ; Jeffrey A. Zidichouski [Canada] ; JUN YANG [Canada] ; CAI SONG [Canada]Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices
002196 (2008) Marc Morissette [Canada] ; Sara Al Sweidi ; Sophie Callier ; Thérèse Di PaoloEstrogen and SERM neuroprotection in animal models of Parkinson's disease.
002806 (2006) Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors
002905 (2006) J. Miklossy [Canada] ; D. D. Doudet [Canada] ; C. Schwab [Canada] ; S. Yu [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Role of ICAM-1 in persisting inflammation in parkinson disease and MPTP monkeys
002925 (2006) Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada]Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of parkinson's disease
002D83 (2003) Nancy Bélanger [Canada] ; Laurent Grégoire ; Paul Bédard ; Thérèse Di PaoloEstradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
002F15 (2003) Pershia Samadi [Canada] ; Laurent Gregoire [Canada] ; Paul J. Bedard [Canada]Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems
003237 (2001) Frédéric Calon [Canada] ; Nadia Lavertu [Canada] ; Anne-Marie Lemieux [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter
003545 (2000) Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo125I-CGP 64213 Binding to GABAB Receptors in the Brain of Monkeys: Effect of MPTP and Dopaminomimetic Treatments
003871 (1998) D J Doudet [Canada] ; G L Chan ; J E Holden ; E G Mcgeer ; T A Aigner ; R J Wyatt ; T J Ruth6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
003A98 (1997) Marc Morissette [Canada] ; Martin Goulet [Canada] ; Jean-Jacques Soghomonian [Canada] ; Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with l-DOPA therapy
003C40 (1997) R. Grondin [Canada] ; P. J. Bedard [Canada] ; D. R. Britton [États-Unis] ; K. Shiosaki [États-Unis]Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929 : An acute study in parkinsonian levodopa-primed monkeys
003C55 (1997) N. A. Tatton [Canada] ; S. J. Kish [Canada]In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and Acridine Orange Staining
003C91 (1996) A. Parent [Canada] ; M C Asselin ; P Y CôtéDopaminergic regulation of peptide gene expression in the striatum of normal and parkinsonian monkeys.
003E98 (1996) M. Goulet [Canada] ; R. Grondin ; P. J. Blanchet ; P. J. Bedard ; T. Di Paolo [Canada]Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode to not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys
004027 (1995) F. Calon [Canada] ; M. Goulet [Canada] ; P. J. Blanchet [Canada] ; J. C. Martel [Canada] ; M. F. Piercey [États-Unis] ; P. J. Be Dard [Canada] ; T. Di Paolo [Canada]Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA, receptors in the striatopallidal complex

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022